Drug Approval | July 26, 2023
Lupin receives approval from TGA Australia for Tiotropium Dry Powder
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Good momentum in commercial CDMO business
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
CMOs showed an increasing reluctance to take on debt in 2022
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Subscribe To Our Newsletter & Stay Updated
